drugset

drugset / Trial / NCT00879554

A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors

NCT00879554 ↗

Phase 1 Completed 40 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to determine safety and tolerability of CVX-045 in patients with advanced solid tumors.

Timeline

Start: 2007-02
Primary completion: 2009-03
Completion: 2010-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CVX-045	Unknown	—	Intravenous

Indications